Haleon (LON:HLN) Shares Down 1.1% – What’s Next?

Haleon plc (LON:HLN) shares dropped 1.1% on Tuesday . The stock traded as low as GBX 374.50 ($4.86) and last traded at GBX 374.50 ($4.86). Approximately 10,110,692 shares were traded during trading, a decline of 49% from the average daily volume of 19,871,000 shares. The stock had previously closed at GBX 378.50 ($4.91).

Analyst Ratings Changes

Separately, Berenberg Bank raised their target price on shares of Haleon from GBX 410 ($5.32) to GBX 447 ($5.80) and gave the company a “buy” rating in a research note on Monday, August 5th.

Haleon Stock Down 0.3 %

The company has a debt-to-equity ratio of 54.18, a current ratio of 0.84 and a quick ratio of 0.93. The company’s 50-day simple moving average is GBX 384.36 and its 200 day simple moving average is GBX 352.90. The firm has a market cap of £33.66 billion, a P/E ratio of 3,091.67, a price-to-earnings-growth ratio of 1.49 and a beta of 0.19.

Haleon Company Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.